{
  "id": 16541596,
  "title": "Double-digit growth seen on corporate scoreboard in Q2, but bank, IT, pharma lag",
  "url": "https://urgent.news/2026/10/26/double-digit-growth-seen-on-corporate-scoreboard-in-q2-but-bank-it",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T00:56:52.000Z",
  "source": {
    "name": "The Economic Times - Top News",
    "slug": "the-economic-times-top-news",
    "url": "https://economictimes.indiatimes.com/markets/stocks/earnings/double-digit-growth-seen-on-corporate-scoreboard-in-q2-but-bank-it-pharma-lags/articleshow/135200205.cms"
  },
  "original_language": "en",
  "account": "Mumbai: Early indications from September quarter earnings suggest double-digit growth in aggregate revenue and net profit across the board, though banking, IT, and pharmaceutical companies lag behind. Of the 357 companies that have released their September quarter numbers so far, revenue expanded at a nine-quarter high of 22.1% year-on-year, while net profit growth accelerated to 27.5%, outpacing the 9.7% increase seen in the previous June quarter. The low base from the year-ago quarter, with revenue and profit growth shrinking by 6.7% and 12.4% respectively, also contributed to the positive trend. However, the operating margin declined by 150 basis points year-on-year to 20.8%, indicating weaker profitability in the banking sector due to persistently low net interest margins. When the lending sector is excluded, operating margin improved by 20 basis points to 15.1%. Excluding banking and finance companies, revenue and profit growth rose to 26.9% and 33.9%, respectively. The share of the lending sector in revenue and profit fell by 34.8% and 54.6%, respectively, compared to the year-ago quarter. The IT sector's contribution to revenue and net profit also declined, accounting for 15.5% and 18.1% respectively, down from 16.8% and 20.4% year-on-year. Analysts had expected double-digit growth in aggregate revenue and net profit for the covered companies, driven by a broad-based momentum, with sectors like automobiles, consumer discretionary, industrials, and nonbanking financial services expected to deliver such growth rates.",
  "summary": "September quarter earnings exhibited significant revenue and profit growth for various companies in key sectors. Revenue rose by 22.1% with net profit increasing by 27.5%, surpassing the previous quarter. However, banking, IT, and pharmaceuticals sectors experienced a slow down in growth rates. Excluding lending, operating margins improved, indicating stronger performance in non-banking sectors.…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}